We are live on ! Find out more
KC

Kepos Capital Portfolio holdings

AUM $61.3M
1-Year Est. Return 12.13%
This Fund
S&P 500
This Quarter Est. Return
-1.94%
1 Year Est. Return
+12.13%
3 Year Est. Return
+22.16%
5 Year Est. Return
10 Year Est. Return
AUM
$1.48B
AUM Growth
+$138M
Cap. Flow
+$173M
Cap. Flow %
11.63%
Top 10 Hldgs %
10.38%
Holding
695
New
242
Increased
60
Reduced
117
Closed
117
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WINT
401
DELISTED
Windtree Therapeutics
WINT
$340K 0.02%
4
ATHN.WS
402
DELISTED
Athena Technology Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one shar
ATHN.WS
$340K 0.02%
+250,000
New +$336K
STWOU
403
DELISTED
ACON S2 Acquisition Corp Unit
STWOU
$338K 0.02%
31,100
BWACU
404
DELISTED
Better World Acquisition Corp. Unit
BWACU
$335K 0.02%
31,400
EVGO icon
405
EVgo
EVGO
$223M
$334K 0.02%
+41,000
New +$414K
CKPT
406
DELISTED
Checkpoint Therapeutics
CKPT
$330K 0.02%
+10,000
New +$296K
VMI icon
407
Valmont Industries
VMI
$9.3B
$325K 0.02%
1,382
-145
-9% -$34.5K
NGAB.U
408
DELISTED
Northern Genesis Acquisition Corp. II Units, each consisting of one share of common stock and one-th
NGAB.U
$325K 0.02%
31,700
-48,500
-60% -$500K
ALB icon
409
Albemarle
ALB
$13.9B
$323K 0.02%
1,473
-258
-15% -$55.1K
QSI icon
410
Quantum-Si Incorporated
QSI
$155M
$321K 0.02%
+38,500
New +$379K
KTTAW icon
411
Pasithea Therapeutics Warrants
KTTAW
$320K 0.02%
+400,000
New +$312K
MDH.WS
412
DELISTED
MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
MDH.WS
$317K 0.02%
+575,000
New +$369K
NUWE icon
413
Nuwellis
NUWE
$160K
0
VHAQ.WS
414
DELISTED
Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share
VHAQ.WS
$314K 0.02%
1,256,705
PAFOR
415
DELISTED
Pacifico Acquisition Corp. Rights
PAFOR
$314K 0.02%
+805,000
New +$306K
IMPX.U
416
DELISTED
AEA-Bridges Impact Corp Units
IMPX.U
$308K 0.02%
30,500
VTAQR
417
DELISTED
Ventoux CCM Acquisition Corp. Right
VTAQR
$308K 0.02%
1,762,200
DCRNU
418
DELISTED
Decarbonization Plus Acquisition Corporation II Unit
DCRNU
$307K 0.02%
29,800
BOAC.U
419
DELISTED
Bluescape Opportunities Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-half of one redeemable warrant
BOAC.U
$304K 0.02%
29,600
IVAN.U
420
DELISTED
Ivanhoe Capital Acquisition Corp. Unit, each consisting of one Class A ordinary share and one-third
IVAN.U
$304K 0.02%
29,200
HTPA.WS
421
DELISTED
Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HTPA.WS
$302K 0.02%
+201,439
New +$226K
MCAFR
422
DELISTED
Mountain Crest Acquisition Corp. IV Rights
MCAFR
$299K 0.02%
+747,450
New +$296K
VHAQ.RT
423
DELISTED
Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock
VHAQ.RT
$297K 0.02%
1,448,405
TE.WS
424
DELISTED
T1 Energy Inc Warrants
TE.WS
$296K 0.02%
+100,000
New +$214K
BHIL.WS
425
DELISTED
Benson Hill, Inc. Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50
BHIL.WS
$293K 0.02%
+207,625
New +$293K

Similar funds

Kepos Capital's Q3 2021 Portfolio in Review

As of Q3 2021, Kepos Capital held 695 positions worth $1.48B, up 10% from $1.35B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Kepos Capital deployed $173M of net new capital in Q3 2021, opening 242 new positions and adding to 60 existing holdings. Its largest new stake was MSP Recovery Inc: 514 shares worth $22.3M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 18% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Montes Archimedes Acquisition Corp. Class A Common Stock, an estimated $11.4M trimmed.

  • Kepos Capital's largest Q3 2021 buy was MSP Recovery Inc: 514 shares worth $22.3M.
  • Kepos Capital added most to indie Semiconductor in Q3 2021, an estimated $4.46M increase.
  • Kepos Capital's biggest Q3 2021 reduction was Montes Archimedes Acquisition Corp. Class A Common Stock, cutting an estimated $11.4M.
  • Kepos Capital fully exited Thunder Bridge Capital Partners IV, Inc. Unit in Q3 2021, selling an estimated $15.7M.
  • Kepos Capital's ten largest holdings make up 10% of its $1.48B portfolio in Q3 2021.
  • Kepos Capital opened 242 new positions and closed 117 in Q3 2021.
  • Kepos Capital's portfolio value rose 10% quarter-over-quarter to $1.48B.

Based on Kepos Capital's 13F filing for Q3 2021, filed 12 Nov 2021.